Effect of Extracorporeal Shock Wave Therapy on Spasticity and Mobility in Stroke Patients
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorIstanbul Medipol University Hospital
About this trial
This study aims to evaluate the effectiveness of extracorporeal shock wave therapy (ESWT) in individuals with lower limb spasticity following stroke. Spasticity is a common complication after stroke and can negatively affect walking ability, mobility, and quality of life.
Participants will be randomly assigned to one of two groups. Both groups will receive a standard physiotherapy and rehabilitation program. In addition, the intervention group will receive ESWT applied to the lower limb muscles, while the control group will receive a sham (placebo) ESWT application.
The treatment program will be conducted three times per week for four weeks. Clinical assessments will be performed at baseline, after treatment, and during follow-up.
The main outcomes of the study include muscle tone (spasticity), walking performance, motor function, and quality of life. The results of this study may help improve rehabilitation strategies and provide evidence for the use of ESWT in stroke patients.
Eligibility criteria
Qualifiers
Adults aged 18-65 years
Diagnosed with ischemic or hemorrhagic stroke at least 3 months prior to enrollment Presence of lower extremity spasticity with a Modified Ashworth Scale (MAS) score ≥1+
Ability to walk independently with or without assistive devices
Ability to understand and follow instructions for exercise interventions and assessments
Disqualifiers
Receipt of botulinum toxin injection in the affected lower limb within the last 3 months
Severe cognitive impairment preventing participation in assessments
Presence of fixed joint contractures limiting range of motion
Orthopedic or musculoskeletal disorders affecting lower limb function (e.g., fracture, severe osteoarthritis)
Trial design
Treatments tested in this trial
- Extracorporeal Shock Wave Therapy (ESWT)
- Sham Extracorporeal Shock Wave Therapy
Treatment groups
85 Participants
are divided into 2 treatment groupsLocations
Sponsors and collaborators
Source ClinicalTrials.gov